Clinical Intelligence Market Report 2026

The clinical intelligence market size has grown rapidly in recent years. It will grow from $10.4 billion in 2025 to $11.89 billion in 2026 at a compound annual growth rate (CAGR) of 14.3%. The growth in the historic period can be attributed to expansion of electronic health record adoption, growing healthcare data volumes, increased focus on clinical workflow optimization, rising demand for data-driven healthcare decisions, advancements in health analytics platforms.

The clinical intelligence market size is expected to see rapid growth in the next few years. It will grow to $20.51 billion in 2030 at a compound annual growth rate (CAGR) of 14.6%. The growth in the forecast period can be attributed to increasing investments in digital health transformation, rising demand for personalized and predictive care, expansion of cloud-based clinical intelligence platforms, growing adoption of ai-enabled diagnostics, increasing regulatory focus on healthcare data utilization. Major trends in the forecast period include increasing adoption of AI-driven clinical decision support tools, rising use of predictive analytics in healthcare, growing integration of ehr and clinical data platforms, expansion of population health intelligence solutions, enhanced focus on real-time clinical insights.

The rising adoption of electronic health records (EHRs) has driven growth in the clinical intelligence market in recent years. Electronic health records (EHRs) are digital versions of patients’ medical histories maintained over time, encompassing comprehensive health information such as diagnoses, treatments, medications, and test results accessible to authorized healthcare providers. The increase in EHR adoption is driven by digital transformation in healthcare, which improves data accessibility and enhances coordination among healthcare providers, ultimately leading to better patient outcomes. Clinical intelligence supports EHRs by analyzing large volumes of patient data to generate actionable insights, enabling providers to make data-driven decisions that improve care quality, efficiency, and patient outcomes. For example, in June 2023, according to the UK Parliament, 90% of NHS trusts had implemented electronic health records by December 2023, with full adoption projected by March 2025. Therefore, the growing adoption of EHRs fueled the expansion of the clinical intelligence market.

Key players in the clinical intelligence market are focusing on AI-driven solutions, such as digital triage, to enhance patient assessment, streamline workflows, and improve clinical decision-making. Digital triage involves AI-powered tools or software that assess patient symptoms, prioritize care, and direct patients to the appropriate clinical pathway efficiently. For instance, in July 2025, Experity Inc., a US-based software and services company, launched Care Agent, the industry’s first clinical intelligence solution tailored for urgent care. The platform integrates AI with electronic medical records to streamline clinic operations and enhance patient engagement. It enables secure communication via web chat and SMS in a HIPAA-compliant manner, without requiring additional apps. Its modular capabilities allow clinics to select features such as digital discharge delivery, lab results communication, and future enhancements including triage assessments and appointment reminders.

In January 2023, Det Norske Veritas (DNV), a Norway-based risk management and assurance company, acquired Medicare Beneficiary Identifier (MBI) for an undisclosed amount. This acquisition allows DNV to strengthen its presence in the digital health sector by leveraging MBI Healthcare Technologies’ AI-driven data assurance solutions to enhance patient safety, improve care efficiency, and address inaccuracies in electronic health records. Medicare Beneficiary Identifier (MBI) is a UK-based company providing clinical intelligence through AI-backed technology and data quality expertise.

Major companies operating in the clinical intelligence market are Microsoft Corporation, Alphabet Inc. (Google LLC), Amazon Web Services (AWS), Optum (UnitedHealth Group), International Business Machines (IBM) Corporation, IQVIA, GE Healthcare Technologies, Inc., Koninklijke Philips N.V., Medtronic Plc, Medidata, AvoMD, Zebra Medical Vision, Teledoc Health, Health Catalyst, Tempus, PathAI, Biofourmis, Twin Health, BenevolentAI, Prometheus Biosciences, Abridge, Owkin, Insitro, Heidi Health, Pieces Technologies, Renalytix PLC, OpenEvidence, Bayesian Health, and SmarterDx.

North America was the largest region in the clinical intelligence market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the clinical intelligence market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the clinical intelligence market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Tariffs are impacting the clinical intelligence market by increasing costs of imported servers, data storage systems, networking hardware, and advanced analytics infrastructure used in on-premise and hybrid deployments. Hospitals and research institutions in North America and Europe are most affected due to reliance on imported IT hardware, while Asia-Pacific faces cost pressure on infrastructure expansion. These tariffs are increasing deployment costs and slowing system upgrades. However, they are also encouraging cloud-based adoption, regional data center investments, and greater reliance on locally sourced digital health infrastructure.

The clinical intelligence market research report is one of a series of new reports that provides clinical intelligence market statistics, including clinical intelligence industry global market size, regional shares, competitors with a clinical intelligence market share, detailed clinical intelligence market segments, market trends and opportunities, and any further data you may need to thrive in the clinical intelligence industry. This clinical intelligence market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Clinical intelligence is the application of advanced data analytics and information systems to gather, process, and interpret healthcare data from diverse sources, including electronic health records (EHRs), laboratory results, and patient monitoring systems. Its main goal is to deliver actionable insights that enable healthcare providers to improve patient outcomes, streamline clinical workflows, and make informed decisions in medical care.

The main components of clinical intelligence are software, hardware, and services. Software includes data analytics and decision-support platforms that collect, integrate, and analyze clinical information to enhance patient care, optimize workflows, and support evidence-based decision-making. These platforms leverage technologies such as artificial intelligence (AI), machine learning (ML), natural language processing (NLP), predictive analytics, business intelligence, and data mining. Deployment can be on-premises or cloud-based. Clinical intelligence is applied in predictive analytics, clinical decision support, population health management, performance management, reporting and dashboards, and risk management. Key end users include hospitals, diagnostic centers, ambulatory care facilities, research institutes, and pharmaceutical and biotechnology companies.

The clinical intelligence market consists of revenues earned by entities by providing services such as data collection and integration, healthcare analytics, patient monitoring, and reporting and visualization. The market value includes the value of related goods sold by the service provider or included within the service offering. The clinical intelligence market also includes sales of clinical data analytics software, healthcare dashboards, reporting tools, and electronic health record (EHR) integration solutions. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.